Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Laryngoscope. 2019 Jan 30;129(9):2178–2183. doi: 10.1002/lary.27847

Table 1:

Distribution of serum biomarkers in participants at risk of incident hearing impairment (N=1088)

Aldosterone (ng/dL) IGF1 (ng/mL) BDNF (ng/mL)
Mean SD Range Mean SD Range Mean SD Range
Overall 9.1 6.1 2.9 – 63.6 74.3 25.4 20.2 – 238.8 21.6 6.2 2.4 – 63.0
Sex
Men 8.5 5.0 2.9 – 41.9 81.3 24.5 21.4 – 187.8 20.2 5.9 4.4 – 42.3
Women 9.4 6.5 2.9 – 63.6 71.2 25.1 20.2 – 238.8 22.2 6.3 2.4 – 63.0
Age (years)
53–59 8.1 5.4 2.9 – 60.5 75.1 25.0 21.4 – 187.8 21.6 6.2 4.7 – 63.0
60–69 9.2 5.9 2.9 – 63.6 72.7 24.3 23.0 – 219.3 21.8 6.4 6.8 – 60.6
70–79 10.8 7.6 2.9 – 58.6 77.2 28.6 32.7 – 238.8 20.9 6.0 2.4 – 34.3
80+ 9.9 5.9 3.8 – 25.8 67.2 18.5 20.2 – 103.9 21.9 5.6 13.0 – 34.7

p-values for difference of biomarkers by sex (aldosterone: p=0.02, IGF1: p<0.0001, BDNF: p<0.0001)

p-values for difference of biomarkers by age group (aldosterone: p<0.0001, IGF1: p=0.02, BDNF: p=0.11)